In life sciences, where innovation and unpredictability go hand in hand, a straight-line career path is the exception rather ...

EY's Arda Ural provides an assessment of the current life sciences business environment, and reasons for optimism about 2025 despite the uncertainty that comes with a new administration in the U.S.

Memo Therapeutics CEO Erik van den Berg reflects on the strategies and skills needed to build company resilience and navigate ...

It wouldn't be accurate to say that surgeon-turned-healthcare investment banker and consultant Dr. Ali Pashazadeh traded his scalpels for spreadsheets. In fact, he still wields a scalpel quite ...